UK Government And NHS Spending Will Unlock Enduring Opportunities

AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Published
17 Feb 25
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
₹3,072.00
17.9% undervalued intrinsic discount
31 Jul
₹2,521.20
Loading
1Y
-11.6%
7D
1.3%

Author's Valuation

₹3.1k

17.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 6.04%

Shared on23 Apr 25
Fair value Decreased 11%

AnalystConsensusTarget has decreased revenue growth from 13.9% to 12.1%.

Shared on17 Apr 25
Fair value Decreased 0.58%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 4.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 3.57%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 3.41%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 3.33%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on13 Mar 25
Fair value Increased 7.73%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.